Cardiac contractility modulation device-new hope for refractory heart failure patients

Area of Science:

• Biomedical Engineering
• Cardiology
• Medical Devices

Background:

• Advanced heart failure (HF) patients often do not respond to standard medical treatments.
• Device-based therapies are emerging for refractory HF.
• Cardiac contractility modulation (CCM) is an investigational therapy using electrical signals.

Purpose of the Study:

• To investigate the potential of CCM electrical signals as a novel treatment for heart failure.
• To describe the mechanism by which CCM enhances systolic function.

Main Methods:

• CCM involves implanting a device similar to a pacemaker.
• Three pacemaker leads are placed intravenously: one atrial, two ventricular.
• Ventricular leads deliver high-voltage electrical impulses to the myocardium during the absolute refractory period.

Main Results:

• CCM signals enhance systolic function in the failing myocardium.
• CCM does not initiate new contractions or alter the heart's activation sequence.
• CCM application is associated with improved gene expression and left ventricular (LV) remodeling.

Conclusions:

• CCM therapy offers a potential new treatment modality for advanced heart failure.
• The mechanism involves enhancing myocardial contractility and promoting beneficial cardiac remodeling.
• CCM modulates heart muscle contraction strength, distinct from rhythm management devices.